Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pulmonary histiocytic sarcoma with cranial mediastinal involvement in a Brazilian red-rumped agouti. | J Vet Diagn Invest | 2026 | 42116562 | PubTator, text mining | PubMed |
| Evaluation of tumour-infiltrating immune cells and their prognostic value in feline appendicular osteosarcoma: a pilot study. | J Comp Pathol | 2026 | 42025628 | PubTator, text mining | PubMed |
| Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC. | Explor Target Antitumor Ther | 2026 | 42003978 | PubTator, text mining | PubMed |
| Functional genomic profiling of schizophrenia-associated genes reveals key microglial regulators. | Neuropsychopharmacology | 2026 | 41992032 | PubTator, text mining | PubMed |
| CD204 regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following intracerebral hemorrhage. | Sci Rep | 2026 | 41957422 | PubTator, text mining | PubMed |
| Investigating the Role of TNFSF12 in Thyroid Cancer Progression via Single-Cell RNA Sequencing and Integrated Multiomics Analyses. | Mediators Inflamm | 2026 | 41930700 | PubTator, text mining | PubMed |
| Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanoma. | Sci Adv | 2026 | 41920996 | PubTator, text mining | PubMed |
| IOA-244, a novel p110δ PI3K inhibitor, blocks breast tumour progression on either mono- or combined-therapy. | Cell Death Discov | 2026 | 41896205 | PubTator, text mining | PubMed |
| FoxP3+ Cells and PNAd+ Tumour-Associated High Endothelial Venules: Synergistic Prognostic Markers in Oral Tongue Squamous Cell Carcinoma. | Head Neck Pathol | 2026 | 41886024 | PubTator, text mining | PubMed |
| CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 41881460 | PubTator, text mining | PubMed |
| Targeting MSR1+ tumor-associated macrophages enhances the therapeutic efficacy of anti-PD-L1 in hepatocellular carcinoma by suppressing NF-κB pathway activation. | Cancer Lett | 2026 | 41871800 | PubTator, text mining | PubMed |
| Immune cell clustering identifies a CD163⁺/CSF1R⁺ macrophage and neutrophil-enriched phenotype with distinct biological signatures and poor prognosis in angiosarcoma. | Oncoimmunology | 2026 | 41870007 | PubTator, text mining | PubMed |
| Transcriptional competence defines the heterochromatin nucleating potential of isolated MSR units. | Nat Commun | 2026 | 41857002 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| Immunometabolism in lung cancer - The link between metabolism and immune response. | iScience | 2026 | 41797927 | PubTator, text mining | PubMed |
| SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment. | CNS Neurosci Ther | 2026 | 41795144 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| Redefining the immune microenvironment of gliomas in the era of single-cell genomics. | Neurooncol Adv | 2026 | 41769417 | PubTator, text mining | PubMed |
| Altered transposon element-derived genes distort oxygen-free radical scavenger systems in FXD. | NAR Mol Med | 2026 | 41768973 | PubTator, text mining | PubMed |
| Latest surface plasmon resonance advances for G protein-coupled receptors. | J Pharm Anal | 2026 | 41767747 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=2